降低强度增量血液透析的开始不会减少预期寿命并节省资金:RIDDLE研究的结果
Andrea Campo1, Franco Goia2, Roberto Cottino2
1SC Nefrologia e Dialisi, Osp S. Lazzaro, Alba, CN, Italy. andrea_campo@hotmail.com.
Journal of nephrology
|April 23, 2025
概括
每周两次进行血液透析是一种安全且具有成本效益的方法,用于在残留功能患者开始治疗. 这种方法可以保护功能,减少住院病例,在严格的临床监测下证明其可行性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 脏替代疗法治疗 脏替代疗法
- 公共卫生 公共卫生
背景情况:
- 自2001年以来,每周两次进行血液透析一直是阿尔巴医院启动血液透析的标准.
- 这项研究评估了其对患者结果和医疗保健成本的长期影响.
研究的目的:
- 评估每周两次进行血液透析的安全性,可行性和成本效益,用于残留功能的发生性血液透析患者.
- 为了比较长期和短期每周两次进行血液透析的患者之间的结果.
主要方法:
- 在2001年1月至2016年12月期间,选择了残留功能 (尿量超过500毫升/天) 的发生性血液透析患者.
- 患者被跟踪到死亡或2019年12月31日,终点包括生存,血液透析持续时间,残留功能保存和成本节省.
- 亚组分析比较了长期 (≥365天) 和短期 (<365天) 每周两次血液透析的持续时间,并与关键的人口和临床因素相匹配.
主要成果:
- 该研究包括146名患者;中位生存时间为1793天,中位残留功能持续时间为820天.
- 长期每周两次进行血液透析与较低的住院率和非计划透析率,以及更好的残留功能保存 (1353 vs 445 天) 相关.
- 通过节省12,291次血液透析,节省了1,986,226欧元的成本.
结论:
- 每周两次进行血液透析是一种安全,可行和节省成本的方法,用于在残留功能患者中启动血液透析.
- 严格的临床监测对于成功实施这种方法至关重要.
- 这一策略有助于维护残留功能,减少医疗保健支出.
相关概念视频
01:27Dialysis
277
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
277
01:11Renal Failure: Dose Adjustments
69
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
01:17Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404